Intimate Partner Violence During COVID-19 Restrictions: A Study of 30 Countries From the I-SHARE Consortium.

Autor: Campbell L; Center for Population, Family, and Health, University of Antwerp, Belgium.; Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, University of Ghent, Belgium., Tan RKJ; Dermatology Hospital of Southern Medical University, Guangzhou, China.; University of North Carolina Project, Guangzhou, China.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Uhlich M; Department of Psychology, University of Basel, Switzerland., Francis JM; Department of Family Medicine and Primary Care, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa., Mark K; Institute for Sexual and Gender Health, University of Minnesota Medical School, Minneapolis, MN, USA., Miall N; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK., Eleuteri S; Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy., Gabster A; Department of Genomics and Proteomics, Gorgas Memorial Institute for Health Studies, Panama City, Panama.; National Research System, National Secretariat of Science, Technology and Innovation, Panama City, Panama.; Center of Population Sciences for Health Equity, Florida State University, Tallahassee, FL, USA., Shamu S; Health Systems Strengthening Division, Foundation for Professional Development, Pretoria, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Plášilová L; Department of Psychology and Life Sciences, Faculty of Humanities, Charles University, Prague, Czech Republic.; Laboratory of Evolutionary Sexology and Psychopathology, National Institute of Mental Health, Klecany, Czech Republic., Kemigisha E; Mbarara University of Science and Technology, Mbarara, Uganda., Olumide A; Institute of Child Health, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria., Kosana P; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hurtado-Murillo F; Center for Sexual and Reproductive Health, University Hospital Doctor Peset, Valencia, Spain., Larsson EC; Karolinska Institutet, Department of Global Health and Department of Women's and Children's Health, Stockholm, Sweden., Cleeve A; Karolinska Institutet, Department of Global Health and Department of Women's and Children's Health, Stockholm, Sweden.; South General Hospital, Stockholm, Sweden., Calvo González S; Department of Education Sciences, University of Oviedo, Oviedo, Spain., Perrotta G; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina., Fernández Albamonte V; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina., Blanco L; Faculty of Psychology, University of Buenos Aires, Buenos Aires, Argentina., Schröder J; Institute for Sex Research, Sexual Medicine and Forensic Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Adebayo A; Institute of Child Health, University of Ibadan, Ibadan, Nigeria., Hendriks J; Collaboration for Evidence, Research and Impact in Public Health, School of Population Health, Curtin University, Perth, Australia., Saltis H; Collaboration for Evidence, Research and Impact in Public Health, School of Population Health, Curtin University, Perth, Australia., Marks M; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Hospital for Tropical Diseases, University College London Hospital, London, UK.; Division of Infection and Immunity, University College London, London, UK., Wu D; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK., Morroni C; Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.; Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Esho T; Amref International University, Nairobi, Kenya., Briken P; Institute for Sex Research, Sexual Medicine and Forensic Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hlatshwako TG; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ryan R; Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Farid NDN; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Gomez Bravo R; Institute for Health and Behaviour, Department of Behavioural and Cognitive Sciences, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Van de Velde S; Center for Population, Family, and Health, University of Antwerp, Belgium., Tucker JD; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jazyk: angličtina
Zdroj: Journal of interpersonal violence [J Interpers Violence] 2023 Jun; Vol. 38 (11-12), pp. 7115-7142. Date of Electronic Publication: 2023 Jan 26.
DOI: 10.1177/08862605221141865
Abstrakt: Intimate partner violence (IPV) causes substantial physical and psychological trauma. Restrictions introduced in response to the COVID-19 pandemic, including lockdowns and movement restrictions, may exacerbate IPV risk and reduce access to IPV support services. This cross-sectional study examines IPV during COVID-19 restrictions in 30 countries from the International Sexual HeAlth and REproductive Health (I-SHARE) study conducted from July 20th, 2020, to February, 15th, 2021. IPV was a primary outcome measure adapted from a World Health Organization multicountry survey. Mixed-effects modeling was used to determine IPV correlates among participants stratified by cohabitation status. The sample included 23,067 participants from 30 countries. A total of 1,070/15,336 (7.0%) participants stated that they experienced IPV during COVID-19 restrictions. A total of 1,486/15,336 (9.2%) participants stated that they had experienced either physical or sexual partner violence before the restrictions, which then decreased to 1,070 (7.0%) after the restrictions. In general, identifying as a sexual minority and experiencing greater economic vulnerability were associated with higher odds of experiencing IPV during COVID-19 restrictions, which were accentuated among participants who were living with their partners. Greater stringency of COVID-19 restrictions and living in urban or semi-urban areas were associated with lower odds of experiencing IPV in some settings. The I-SHARE data suggest a substantial burden of IPV during COVID-19 restrictions. However, the restrictions were correlated with reduced IPV in some settings. There is a need for investing in specific support systems for survivors of IPV during the implementation of restrictions designed to contain infectious disease outbreaks.
Databáze: MEDLINE